title: Alloreactive T cells discriminate among a diverse set of endogenous peptides.
abstract: Previous studies have demonstrated that class I major histocompatibility complex (MHC) molecules are occupied by peptides of endogenously synthesized self proteins. Since graft rejection appears to be mediated by the normal occurrence of high frequencies of cytolytic T lymphocytes (CTLs) specific for allogeneic MHC molecules, it is important to know if such CTLs recognize specific MHC-peptide complexes (as opposed to the MHC molecule per se) and, if so, whether allorecognition is the result of the recognition of a limited spectrum of antigenic determinants or, alternatively, the recognition of a diverse array of MHC-self peptide complexes. This issue has been examined using a mutant cell line, T2Kb, that expresses class I molecules devoid of endogenously derived peptides. This cell line was not recognized by Kb-specific alloreactive CTLs. However, upon exposure to peptides derived by cyanogen bromide cleavage of cytoplasmic proteins these cells became sensitized for recognition and lysis by a majority of the CTL clones examined. Reverse-phase HPLC fractionation of the heterogeneous cell-derived peptides revealed that individual CTL clones were specific for different peptide antigen(s). Thus, the high frequency of alloreactive T cells that is responsible for graft rejection appears to represent the sum of numerous T-cell clones specific for a diverse array of endogenous peptide antigens presented in the context of allogeneic class I molecules.
authors.affiliation: Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, CA 92037.
authors.forename: W R
authors.initials: WR
authors.lastname: Heath
authors.forename: K P
authors.initials: KP
authors.lastname: Kane
authors.forename: M F
authors.initials: MF
authors.lastname: Mescher
authors.forename: L A
authors.initials: LA
authors.lastname: Sherman
mesh_terms: D000818:Animals; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D003488:Cyanogen Bromide; D005805:Genes, MHC Class I / Q000276:immunology; D006801:Humans; D008285:Major Histocompatibility Complex / Q000276:immunology; D051379:Mice; D009154:Mutation; D010455:Peptides / Q000378:metabolism*; D013379:Substrate Specificity; D013602:T-Lymphocytes, Cytotoxic / Q000378:metabolism*
chemical_list: D010455:Peptides; D003488:Cyanogen Bromide